,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Haemoptysis,6,16679428
1,22.0,Atrial fibrillation,6,16679428
2,22.0,Pulmonary embolism,6,16679428
3,22.0,Interstitial lung disease,6,16679428
4,22.0,Peripheral swelling,6,16679428
0,22.0,Mouth ulceration,2,16679429
1,22.0,Feeding disorder,6,16679429
0,22.0,Condition aggravated,2,16679430
1,22.0,Atrial fibrillation,6,16679430
2,22.0,Drug interaction,2,16679430
3,22.0,Dyspnoea,2,16679430
4,22.0,Chronic obstructive pulmonary disease,2,16679430
5,22.0,Urinary retention,6,16679430
0,22.0,Malignant neoplasm progression,5,16679432
0,22.0,Dermatitis acneiform,1,16679450
0,22.0,Hyposideraemia,1,16679453
1,22.0,Anaemia,1,16679453
0,22.1,Disease progression,1,16679454
1,22.1,Therapy non-responder,1,16679454
0,22.0,Adverse event,6,16679480
0,22.0,Malignant neoplasm progression,5,16679493
0,22.0,Parkinsonism,6,16679506
0,22.0,Vomiting,6,16679549
1,22.0,Gastritis,3,16679549
2,22.0,Oesophagitis,1,16679549
3,22.0,Nausea,1,16679549
0,22.0,Hyperbilirubinaemia,1,16679554
0,22.0,Anaemia,6,16679557
0,22.0,Metastases to ovary,6,16679576
1,22.0,Metastases to lung,3,16679576
2,22.0,Malignant neoplasm progression,6,16679576
3,22.0,Metastases to bone,3,16679576
4,22.0,Hormone level abnormal,3,16679576
5,22.0,Metastases to pelvis,6,16679576
0,22.0,Injection site erythema,1,16679617
1,22.0,White blood cell count increased,2,16679617
2,22.0,Drug-induced liver injury,1,16679617
3,22.0,Injection site pain,1,16679617
4,22.0,Vomiting,1,16679617
0,22.0,Metastases to central nervous system,6,16679630
1,22.0,Platelet count decreased,3,16679630
2,22.0,Anaemia,3,16679630
3,22.0,Malignant neoplasm progression,5,16679630
4,22.0,Metastases to bone,6,16679630
5,22.0,Meningism,6,16679630
6,22.0,White blood cell count decreased,1,16679630
0,22.0,Thrombophlebitis superficial,6,16679669
1,22.0,Nephropathy toxic,6,16679669
2,22.0,White blood cell count decreased,6,16679669
3,22.0,Cellulitis,2,16679669
4,22.0,Deep vein thrombosis,6,16679669
5,22.0,Febrile neutropenia,1,16679669
0,22.0,Colorectal cancer,,16679681
1,22.0,Mouth ulceration,,16679681
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,,16679681
0,22.0,Blood test abnormal,6,16679687
1,22.0,Hospitalisation,6,16679687
0,22.0,Headache,1,16679700
1,22.0,Dizziness,1,16679700
2,22.0,Blood pressure increased,1,16679700
0,22.0,Breast cancer metastatic,6,16679718
1,22.0,Malignant neoplasm progression,6,16679718
0,22.1,Drug ineffective,1,16679725
0,22.0,Hyperglycaemia,6,16679749
0,22.1,Proteinuria,2,16679861
1,22.1,Tubulointerstitial nephritis,6,16679861
2,22.1,Hypertension,6,16679861
3,22.1,Oedema peripheral,6,16679861
0,22.1,Peripheral swelling,1,16679905
1,22.1,Deep vein thrombosis,1,16679905
0,22.0,Anaphylactic shock,1,16679926
0,22.0,Decreased appetite,2,16679952
1,22.0,Chromaturia,2,16679952
2,22.0,Weight decreased,6,16679952
3,22.0,Fatigue,2,16679952
4,22.0,Nausea,2,16679952
5,22.0,Sleep deficit,2,16679952
6,22.0,Depressed mood,6,16679952
7,22.0,Headache,6,16679952
8,22.0,Diarrhoea,2,16679952
9,22.0,Constipation,2,16679952
0,22.0,Decreased appetite,3,16679955
0,22.0,Ileus,3,16680017
0,22.0,Cerebrovascular accident,1,16680049
0,22.0,Hypersensitivity,6,16680051
0,22.1,Prostate cancer metastatic,6,16680089
0,22.0,Blindness transient,1,16680139
1,22.0,Optic disc hyperaemia,1,16680139
0,22.0,Nausea,6,16680192
1,22.0,Visual impairment,6,16680192
2,22.0,Bone disorder,6,16680192
3,22.0,Fall,6,16680192
4,22.0,Vomiting,6,16680192
5,22.0,Dizziness,2,16680192
6,22.0,Hypotension,6,16680192
7,22.0,Nodule,6,16680192
0,22.0,Malignant neoplasm progression,3,16680214
1,22.0,Haematochezia,1,16680214
2,22.0,Ovarian cancer,3,16680214
3,22.0,Product use in unapproved indication,6,16680214
0,22.0,Serotonin syndrome,6,16680259
1,22.0,Drug interaction,6,16680259
0,22.0,Hyperglycaemia,1,16680290
0,22.0,Cerebrovascular accident,6,16680304
0,22.0,Death,5,16680307
0,22.1,Ischaemic stroke,1,16680319
0,22.0,Metastases to liver,6,16680320
0,22.0,Cardiomyopathy,6,16680346
0,22.0,Malignant neoplasm progression,6,16680457
1,22.0,Haemorrhage,5,16680457
2,22.0,Shock haemorrhagic,5,16680457
0,22.1,Road traffic accident,6,16680459
1,22.1,Cerebrovascular accident,6,16680459
2,22.1,Death,5,16680459
0,22.1,Pneumonia aspiration,1,16680467
1,22.1,Decreased appetite,2,16680467
2,22.1,Stevens-Johnson syndrome,2,16680467
3,22.1,Erythema multiforme,2,16680467
4,22.1,Malignant neoplasm progression,5,16680467
5,22.1,Renal disorder,4,16680467
0,22.0,Drug resistance,6,16680470
1,22.0,Malignant neoplasm progression,6,16680470
0,22.0,Malignant neoplasm progression,6,16680471
1,22.0,Drug resistance,6,16680471
0,22.0,Drug resistance,6,16680472
1,22.0,Malignant neoplasm progression,6,16680472
0,22.0,Liver function test abnormal,1,16680473
1,22.0,Malignant neoplasm progression,6,16680473
2,22.0,Mouth ulceration,3,16680473
3,22.0,Drug resistance,6,16680473
4,22.0,Renal impairment,1,16680473
0,22.0,Drug resistance,6,16680474
1,22.0,Malignant neoplasm progression,6,16680474
0,22.0,Malignant neoplasm progression,3,16680475
1,22.0,Drug resistance,3,16680475
0,22.0,Drug resistance,6,16680476
1,22.0,Malignant neoplasm progression,6,16680476
0,22.0,Malignant neoplasm progression,6,16680490
1,22.0,Drug resistance,6,16680490
0,22.0,Drug resistance,6,16680491
1,22.0,Malignant neoplasm progression,6,16680491
0,22.0,Drug resistance,6,16680492
1,22.0,Malignant neoplasm progression,6,16680492
2,22.0,Pruritus,1,16680492
3,22.0,Diarrhoea,3,16680492
0,22.0,Drug resistance,6,16680493
1,22.0,Vascular injury,6,16680493
2,22.0,Cough,3,16680493
3,22.0,Malignant neoplasm progression,6,16680493
0,22.0,Malignant neoplasm progression,6,16680504
1,22.0,Drug resistance,6,16680504
2,22.0,Skin mass,1,16680504
3,22.0,Metastases to central nervous system,6,16680504
4,22.0,Nasal discharge discolouration,1,16680504
0,22.0,Malignant neoplasm progression,6,16680505
1,22.0,Drug resistance,6,16680505
0,22.0,Drug resistance,6,16680506
1,22.0,Carcinoembryonic antigen increased,6,16680506
2,22.0,Weight decreased,6,16680506
3,22.0,Malignant neoplasm progression,6,16680506
0,22.0,Fatigue,6,16680515
1,22.0,Rash,6,16680515
2,22.0,Constipation,6,16680515
3,22.0,Colon cancer metastatic,6,16680515
0,22.0,Neuroendocrine tumour,6,16680557
0,22.0,Pneumonia,5,16680635
1,22.0,Vascular device infection,5,16680635
0,22.0,Nausea,6,16680727
1,22.0,Back pain,6,16680727
2,22.0,Hypoaesthesia,6,16680727
3,22.0,Musculoskeletal pain,6,16680727
4,22.0,Headache,6,16680727
5,22.0,Blood phosphorus decreased,6,16680727
0,22.0,Hepatic function abnormal,6,16680769
1,22.0,Hepatitis,6,16680769
0,22.1,Metastases to central nervous system,6,16680798
1,22.1,Nerve compression,6,16680798
2,22.1,Malignant neoplasm progression,6,16680798
3,22.1,Rash,6,16680798
4,22.1,Drug resistance,6,16680798
5,22.1,Pruritus,1,16680798
0,22.0,Malignant neoplasm progression,6,16680799
1,22.0,Drug resistance,6,16680799
0,22.0,Malignant neoplasm progression,6,16680800
1,22.0,Drug resistance,6,16680800
0,22.0,Malignant neoplasm progression,6,16680801
1,22.0,Drug resistance,6,16680801
2,22.0,Dizziness,1,16680801
0,22.0,Gastrointestinal disorder,1,16680809
0,22.1,Headache,3,16680818
1,22.1,Pigmentation disorder,6,16680818
2,22.1,Chromaturia,3,16680818
3,22.1,Urine odour abnormal,3,16680818
4,22.1,Injection site mass,3,16680818
5,22.1,Alopecia,3,16680818
6,22.1,Therapeutic response unexpected,6,16680818
7,22.1,Bone pain,3,16680818
8,22.1,Insulin-like growth factor abnormal,6,16680818
0,22.0,Malignant neoplasm progression,6,16680827
1,22.0,Drug resistance,6,16680827
0,22.0,Cough,6,16680828
1,22.0,Feeling abnormal,6,16680828
2,22.0,Drug resistance,3,16680828
3,22.0,Vomiting,6,16680828
4,22.0,Pyrexia,2,16680828
5,22.0,Malignant neoplasm progression,5,16680828
6,22.0,Coma,6,16680828
0,22.0,Drug resistance,6,16680829
1,22.0,Malignant neoplasm progression,6,16680829
0,22.0,Malignant neoplasm progression,6,16680830
1,22.0,Drug resistance,6,16680830
0,22.0,Drug resistance,6,16680831
1,22.0,Malignant neoplasm progression,6,16680831
0,22.0,Malignant neoplasm progression,6,16680832
1,22.0,Rash,1,16680832
2,22.0,Drug resistance,6,16680832
3,22.0,Mental disorder,6,16680832
0,22.0,Rash,2,16680833
1,22.0,Drug resistance,6,16680833
2,22.0,Malignant neoplasm progression,6,16680833
3,22.0,Pruritus,2,16680833
0,22.0,Drug resistance,6,16680834
1,22.0,Malignant neoplasm progression,6,16680834
0,22.0,Drug resistance,6,16680835
1,22.0,Malignant neoplasm progression,6,16680835
0,22.0,Malignant neoplasm progression,6,16680836
1,22.0,Drug resistance,6,16680836
0,22.1,Cholecystitis acute,1,16680841
1,22.1,Sepsis,6,16680841
2,22.1,Drug-induced liver injury,1,16680841
3,22.1,Cholangitis acute,1,16680841
0,22.1,Dyspnoea,1,16680851
1,22.1,Tremor,1,16680851
2,22.1,White blood cell count increased,1,16680851
3,22.1,Chemotherapy,6,16680851
0,22.1,Interstitial lung disease,1,16680905
0,22.0,Liver disorder,6,16680946
1,22.0,Renal disorder,6,16680946
0,22.0,Brugada syndrome,2,16680953
1,22.0,White blood cell count decreased,6,16680953
2,22.0,Cough,6,16680953
3,22.0,Ventricular extrasystoles,2,16680953
4,22.0,Productive cough,6,16680953
5,22.0,Pyrexia,6,16680953
0,22.0,Blood pressure increased,2,16680984
0,22.0,Drug ineffective,6,16680997
1,22.0,Malignant neoplasm progression,6,16680997
2,22.0,Pulmonary oedema,3,16680997
3,22.0,Pleural thickening,6,16680997
0,22.0,Nephrolithiasis,6,16681017
0,22.0,Off label use,6,16681034
1,22.0,Neutropenic sepsis,6,16681034
2,22.0,Product use in unapproved indication,6,16681034
0,22.0,Tumour pseudoprogression,6,16681112
0,22.0,Thyroid cancer,5,16681137
0,22.0,Death,5,16681145
0,22.0,Gait disturbance,6,16681254
1,22.0,Disease progression,6,16681254
2,22.0,Neuropathy peripheral,6,16681254
3,22.0,Myopathy,2,16681254
0,22.0,Lung disorder,2,16681269
0,22.1,Basedow^s disease,1,16681298
0,22.0,Infusion related reaction,1,16681325
1,22.0,Dyspnoea,1,16681325
2,22.0,Erythema,1,16681325
0,22.0,Platelet count decreased,6,16681357
1,22.0,Neutropenia,1,16681357
2,22.0,Haemoglobin decreased,6,16681357
3,22.0,White blood cell count decreased,6,16681357
4,22.0,Red blood cell count decreased,6,16681357
0,22.1,Chronic kidney disease,3,16681358
1,22.1,Myocardial infarction,3,16681358
2,22.1,Pain,6,16681358
0,22.0,Drug resistance,6,16681363
1,22.0,Malignant neoplasm progression,6,16681363
0,22.1,Nausea,2,16681376
1,22.1,Oral pain,6,16681376
2,22.1,Dyspnoea exertional,3,16681376
3,22.1,Inflammation,2,16681376
4,22.1,Dyspnoea,6,16681376
5,22.1,Haemoglobin decreased,2,16681376
6,22.1,Musculoskeletal pain,3,16681376
7,22.1,Diarrhoea,3,16681376
8,22.1,Taste disorder,6,16681376
9,22.1,Depression,6,16681376
10,22.1,Fatigue,3,16681376
11,22.1,Product dose omission,6,16681376
12,22.1,Neuropathy peripheral,3,16681376
13,22.1,Red blood cell count decreased,3,16681376
14,22.1,Bone disorder,6,16681376
15,22.1,Pain in extremity,3,16681376
16,22.1,Somnolence,1,16681376
17,22.1,Laboratory test abnormal,6,16681376
0,22.0,Evans syndrome,2,16681379
1,22.0,Therapy partial responder,6,16681379
2,22.0,Disease progression,6,16681379
0,22.0,Pharyngeal swelling,2,16681395
0,22.0,Blood calcium decreased,3,16681398
0,22.0,Fall,1,16681400
1,22.0,Hypotension,1,16681400
0,22.0,Malignant neoplasm progression,6,16681407
1,22.0,Drug resistance,6,16681407
0,22.0,Protein total decreased,2,16681409
0,22.1,Tumour pseudoprogression,6,16681419
1,22.1,Intentional product use issue,6,16681419
2,22.1,Malignant neoplasm progression,6,16681419
0,22.0,Blood urea increased,2,16681424
0,22.1,Dizziness,6,16681452
1,22.1,Decreased appetite,6,16681452
2,22.1,Metastases to liver,6,16681452
3,22.1,Asthenia,6,16681452
4,22.1,Fatigue,6,16681452
5,22.1,Pyrexia,6,16681452
6,22.1,Diarrhoea,6,16681452
7,22.1,Vomiting,6,16681452
8,22.1,Weight decreased,6,16681452
0,22.0,Pneumothorax,1,16681463
0,22.0,Hypomagnesaemia,6,16681474
0,22.1,Pyrexia,4,16681530
1,22.1,Febrile neutropenia,3,16681530
2,22.1,Neutropenia,4,16681530
3,22.1,Asthenia,4,16681530
0,22.0,Death,5,16681541
0,22.0,Blood creatinine increased,6,16681551
1,22.0,Nausea,3,16681551
2,22.0,Decreased appetite,1,16681551
3,22.0,Diarrhoea,1,16681551
4,22.0,Depression,3,16681551
5,22.0,Asthenia,1,16681551
6,22.0,Renal failure,3,16681551
7,22.0,Taste disorder,1,16681551
8,22.0,Constipation,3,16681551
9,22.0,Fatigue,2,16681551
0,22.0,Skin ulcer,6,16681556
0,22.0,Drug resistance,6,16681589
1,22.0,Malignant neoplasm progression,6,16681589
0,22.0,General physical health deterioration,6,16681610
0,22.1,Product use issue,6,16681618
1,22.1,Wrong technique in product usage process,6,16681618
2,22.1,Varices oesophageal,2,16681618
0,22.0,Ataxia,6,16681681
1,22.0,Dizziness,6,16681681
2,22.0,Visual impairment,6,16681681
3,22.0,Encephalitis,3,16681681
0,22.0,Abdominal pain upper,,16681687
1,22.0,Epigastric discomfort,,16681687
0,22.1,Arthralgia,6,16681690
1,22.1,Nausea,6,16681690
2,22.1,Prostatic specific antigen increased,6,16681690
3,22.1,Fatigue,6,16681690
4,22.1,Malignant neoplasm progression,5,16681690
5,22.1,Urinary retention,6,16681690
6,22.1,Dizziness,6,16681690
7,22.1,Decreased appetite,6,16681690
8,22.1,Back pain,6,16681690
0,22.0,Cardiac dysfunction,6,16681702
0,22.0,Dyspnoea,2,16681706
1,22.0,Interstitial lung disease,3,16681706
0,22.0,Weight decreased,6,16681717
1,22.0,Stress,6,16681717
2,22.0,Muscle disorder,6,16681717
3,22.0,Diarrhoea,6,16681717
0,22.0,Cardiac dysfunction,6,16681720
0,22.0,Death,5,16681738
1,22.0,Intentional product use issue,6,16681738
2,22.0,Thrombosis,6,16681738
3,22.0,Off label use,6,16681738
0,22.0,Back disorder,6,16681744
1,22.0,Renal disorder,6,16681744
2,22.0,Abdominal discomfort,6,16681744
0,22.0,Back pain,1,16681761
1,22.0,Rash,1,16681761
2,22.0,Hypertensive crisis,1,16681761
0,22.0,Thyroiditis,3,16681785
0,22.0,Nausea,5,16681861
1,22.0,Chest discomfort,5,16681861
2,22.0,Blood creatine phosphokinase MB increased,6,16681861
3,22.0,Pericardial effusion,6,16681861
4,22.0,Arthralgia,6,16681861
5,22.0,Cardiogenic shock,5,16681861
6,22.0,Pneumonia,5,16681861
7,22.0,Left ventricular failure,5,16681861
8,22.0,Aspartate aminotransferase increased,6,16681861
9,22.0,Left ventricular dilatation,6,16681861
10,22.0,Lymphatic obstruction,6,16681861
11,22.0,Troponin I increased,6,16681861
12,22.0,Blood lactate dehydrogenase increased,6,16681861
13,22.0,C-reactive protein increased,6,16681861
14,22.0,Blood glucose increased,6,16681861
15,22.0,Acute myocardial infarction,5,16681861
16,22.0,Metastases to lung,6,16681861
17,22.0,General physical health deterioration,6,16681861
18,22.0,Left atrial dilatation,6,16681861
19,22.0,Musculoskeletal deformity,6,16681861
20,22.0,Hepatic steatosis,6,16681861
21,22.0,Fibrin D dimer increased,6,16681861
22,22.0,Blood creatine phosphokinase increased,6,16681861
23,22.0,Dyspnoea,5,16681861
24,22.0,Atrioventricular block,6,16681861
25,22.0,Blood gases abnormal,6,16681861
26,22.0,Aortic arteriosclerosis,6,16681861
27,22.0,Tachycardia,5,16681861
28,22.0,Vomiting,5,16681861
29,22.0,Blood creatinine increased,6,16681861
30,22.0,Soft tissue inflammation,6,16681861
31,22.0,Lymphadenopathy,6,16681861
32,22.0,Laryngeal oedema,6,16681861
33,22.0,Reflux laryngitis,6,16681861
34,22.0,Hypotension,5,16681861
35,22.0,Arteriosclerosis coronary artery,6,16681861
0,22.0,Tumour flare,6,16681862
0,22.0,Nausea,6,16681863
1,22.0,Neutropenia,6,16681863
2,22.0,Neutropenic colitis,6,16681863
3,22.0,Diarrhoea,6,16681863
4,22.0,Septic shock,6,16681863
0,22.0,Scleritis,6,16681868
1,22.0,Headache,6,16681868
0,22.1,Syncope,1,16681888
0,22.0,Nausea,1,16681953
1,22.0,Ischaemic stroke,6,16681953
0,22.0,Drug resistance,6,16682152
1,22.0,Malignant neoplasm progression,6,16682152
0,22.1,Asthenia,6,16682153
1,22.1,Malignant neoplasm progression,6,16682153
2,22.1,Wheezing,6,16682153
3,22.1,Diarrhoea,3,16682153
4,22.1,Pleural effusion,6,16682153
5,22.1,Weight increased,6,16682153
6,22.1,Drug resistance,6,16682153
0,22.0,Drug resistance,6,16682154
1,22.0,Malignant neoplasm progression,6,16682154
0,22.0,Malignant neoplasm progression,6,16682156
1,22.0,Drug resistance,6,16682156
0,22.0,Drug resistance,6,16682157
1,22.0,Malignant neoplasm progression,6,16682157
0,22.0,Drug resistance,6,16682159
1,22.0,Malignant neoplasm progression,6,16682159
0,22.0,Oesophageal rupture,6,16682222
1,22.0,Infectious pleural effusion,6,16682222
2,22.0,Chest pain,6,16682222
3,22.0,Cytomegalovirus test positive,6,16682222
4,22.0,Vomiting,6,16682222
5,22.0,Suture rupture,6,16682222
6,22.0,Diarrhoea,6,16682222
7,22.0,Malnutrition,6,16682222
0,22.0,Vomiting,6,16682239
1,22.0,Dizziness,6,16682239
2,22.0,Pneumonia,6,16682239
3,22.0,Headache,6,16682239
0,22.0,Drug ineffective,6,16682241
0,22.1,Fall,6,16682252
1,22.1,Fibula fracture,6,16682252
2,22.1,Lymphocyte count decreased,6,16682252
0,22.0,Metastases to central nervous system,6,16682258
1,22.0,Drug resistance,6,16682258
2,22.0,Malignant neoplasm progression,6,16682258
0,22.0,Drug resistance,6,16682259
1,22.0,Malignant neoplasm progression,6,16682259
0,22.0,Purulence,6,16682262
1,22.0,Vomiting,6,16682262
2,22.0,Drug resistance,6,16682262
3,22.0,Diarrhoea,6,16682262
4,22.0,Malignant neoplasm progression,6,16682262
5,22.0,Scar,6,16682262
6,22.0,Nausea,6,16682262
7,22.0,Pruritus,6,16682262
0,22.0,Drug resistance,6,16682263
1,22.0,Malignant neoplasm progression,6,16682263
0,22.0,Cough,6,16682264
1,22.0,Drug resistance,6,16682264
2,22.0,Inflammation,6,16682264
3,22.0,Asthma,6,16682264
4,22.0,Malignant neoplasm progression,6,16682264
0,22.0,Drug resistance,6,16682265
1,22.0,Malignant neoplasm progression,6,16682265
0,22.0,Drug resistance,6,16682266
1,22.0,Malignant neoplasm progression,6,16682266
0,22.0,Pancreatitis,1,16682334
0,22.0,Malignant neoplasm progression,6,16682349
1,22.0,Speech disorder,6,16682349
2,22.0,Diarrhoea,6,16682349
3,22.0,Intellectual disability,6,16682349
4,22.0,Drug resistance,6,16682349
5,22.0,Decreased appetite,6,16682349
6,22.0,Motor dysfunction,6,16682349
7,22.0,Drug ineffective,6,16682349
0,22.1,Oesophageal carcinoma,5,16682418
1,22.1,Rash,6,16682418
2,22.1,Extremity necrosis,3,16682418
3,22.1,Skin ulcer,4,16682418
0,22.1,Pneumonia,5,16682426
1,22.1,Vascular device infection,5,16682426
0,22.0,Laryngeal oedema,1,16682434
1,22.0,Respiratory fatigue,1,16682434
0,22.1,Pyrexia,1,16682440
1,22.1,Decreased appetite,1,16682440
2,22.1,Hip fracture,1,16682440
3,22.1,Diarrhoea,1,16682440
4,22.1,Skin infection,1,16682440
5,22.1,Stomatitis,1,16682440
6,22.1,Urinary tract infection,1,16682440
7,22.1,Neuropathy peripheral,1,16682440
8,22.1,Embolism,1,16682440
9,22.1,Neuralgia,1,16682440
10,22.1,Cardiac arrest,5,16682440
11,22.1,Dysphagia,1,16682440
12,22.1,Anaemia,1,16682440
0,22.0,Metastases to lung,6,16682446
1,22.0,Product use in unapproved indication,6,16682446
0,22.0,Drug ineffective,6,16682451
1,22.0,Hyperaesthesia,2,16682451
0,22.0,Myalgia,6,16682462
1,22.0,Back pain,6,16682462
2,22.0,Blood calcium decreased,6,16682462
0,22.0,Death,5,16682485
1,22.0,Lower limb fracture,5,16682485
0,22.0,Malignant neoplasm progression,5,16682544
1,22.0,Drug ineffective,6,16682544
0,22.0,Cerebral infarction,6,16682545
1,22.0,Gastrointestinal haemorrhage,6,16682545
0,22.0,Eye irritation,2,16682547
1,22.0,Dacryostenosis acquired,2,16682547
2,22.0,Ocular hyperaemia,2,16682547
3,22.0,Dry eye,2,16682547
4,22.0,Lacrimation increased,2,16682547
0,22.0,Weight increased,6,16682568
1,22.0,Ligament injury,6,16682568
2,22.0,Drug interaction,6,16682568
3,22.0,Photosensitivity reaction,3,16682568
4,22.0,Colitis,6,16682568
5,22.0,Palpitations,3,16682568
6,22.0,Temperature intolerance,3,16682568
7,22.0,Arthralgia,3,16682568
8,22.0,Weight decreased,3,16682568
9,22.0,Fatigue,3,16682568
10,22.0,Headache,3,16682568
11,22.0,Nephrolithiasis,6,16682568
12,22.0,Ligamentitis,3,16682568
13,22.0,Decreased appetite,3,16682568
14,22.0,Musculoskeletal stiffness,6,16682568
15,22.0,Urticaria,1,16682568
0,22.0,Malignant neoplasm progression,6,16682571
1,22.0,Drug resistance,6,16682571
0,22.0,Malignant neoplasm progression,6,16682572
1,22.0,Drug resistance,6,16682572
0,22.0,Drug resistance,6,16682573
1,22.0,Malignant neoplasm progression,6,16682573
0,22.0,Product use in unapproved indication,6,16682625
1,22.0,Discomfort,6,16682625
2,22.0,Neoplasm progression,6,16682625
3,22.0,Off label use,6,16682625
0,22.0,Diarrhoea,5,16682650
1,22.0,Off label use,6,16682650
2,22.0,Febrile neutropenia,6,16682650
3,22.0,Sepsis,5,16682650
0,22.0,Gout,6,16682661
1,22.0,Cholelithiasis,6,16682661
2,22.0,Hepatic enzyme increased,6,16682661
3,22.0,Inappropriate schedule of product administration,6,16682661
4,22.0,Photosensitivity reaction,6,16682661
0,22.0,Uterine cancer,6,16682662
0,22.0,Skin discolouration,6,16682688
1,22.0,Pruritus,1,16682688
2,22.0,Malignant neoplasm progression,6,16682688
3,22.0,Drug resistance,6,16682688
4,22.0,Diarrhoea,1,16682688
0,22.0,Off label use,6,16682698
1,22.0,Product use in unapproved indication,6,16682698
2,22.0,Death,5,16682698
0,22.0,Dizziness,1,16682712
1,22.0,Abdominal discomfort,1,16682712
2,22.0,Fatigue,1,16682712
3,22.0,Hair growth abnormal,6,16682712
4,22.0,Diarrhoea,1,16682712
0,22.1,Weight decreased,1,16682735
1,22.1,Neoplasm progression,1,16682735
0,22.0,Off label use,,16682824
1,22.0,Hospitalisation,3,16682824
0,22.0,Biliary colic,6,16682825
1,22.0,Stomatitis,6,16682825
2,22.0,Back pain,6,16682825
3,22.0,Abdominal pain,6,16682825
4,22.0,Nausea,6,16682825
5,22.0,Off label use,,16682825
6,22.0,Hospitalisation,6,16682825
7,22.0,Diarrhoea,,16682825
8,22.0,Biliary tract disorder,6,16682825
9,22.0,Fatigue,6,16682825
10,22.0,Skin lesion,6,16682825
0,22.0,Asthenia,2,16682826
1,22.0,Off label use,,16682826
2,22.0,Colorectal cancer,,16682826
0,22.1,Malignant neoplasm progression,5,16682830
1,22.1,Cerebrovascular accident,2,16682830
2,22.1,Asthenia,2,16682830
3,22.1,Decreased appetite,2,16682830
4,22.1,Constipation,2,16682830
0,22.0,Drug resistance,6,16682833
1,22.0,Malignant neoplasm progression,6,16682833
0,22.0,Drug resistance,6,16682837
1,22.0,Malignant neoplasm progression,6,16682837
0,22.0,Throat irritation,,16682871
1,22.0,Cough,,16682871
2,22.0,Infusion related reaction,,16682871
0,22.0,Deep vein thrombosis,2,16682886
0,22.0,Pain,,16682911
1,22.0,Anaemia,,16682911
0,22.0,Malaise,,16682914
0,22.0,Colitis,1,16682939
1,22.0,Nausea,1,16682939
0,22.0,Death,,16682961
0,22.0,Thrombocytopenia,3,16682966
1,22.0,Leukopenia,3,16682966
2,22.0,Prostatic specific antigen increased,3,16682966
0,22.0,Tubulointerstitial nephritis,2,16682968
0,22.0,Neuropathy peripheral,6,16682975
0,22.0,Disease progression,,16683026
0,22.0,Hepatotoxicity,,16683033
1,22.0,Nodular regenerative hyperplasia,,16683033
2,22.0,Iron deficiency anaemia,,16683033
0,22.0,Disease progression,,16683042
0,22.1,Alanine aminotransferase increased,1,16683068
1,22.1,Alanine aminotransferase increased,1,16683068
2,22.1,Hyperthyroidism,3,16683068
3,22.1,Aspartate aminotransferase increased,1,16683068
4,22.1,Aspartate aminotransferase increased,1,16683068
5,22.1,Weight increased,6,16683068
6,22.1,Aspartate aminotransferase increased,1,16683068
0,22.0,Transaminases increased,,16683072
1,22.0,Immune-mediated hepatitis,,16683072
0,22.1,Adverse event,6,16683079
0,22.0,Myocardial ischaemia,6,16683090
0,22.0,Product use in unapproved indication,6,16683091
1,22.0,Inappropriate schedule of product administration,6,16683091
0,22.0,Weight decreased,6,16683100
1,22.0,Taste disorder,3,16683100
2,22.0,Somnolence,6,16683100
3,22.0,Diarrhoea,4,16683100
4,22.0,Rash,1,16683100
5,22.0,Rash erythematous,1,16683100
6,22.0,Heart rate increased,1,16683100
7,22.0,Fatigue,6,16683100
8,22.0,Retching,3,16683100
9,22.0,Pneumonia bacterial,1,16683100
0,22.0,Malignant neoplasm progression,5,16683103
0,22.0,Drug resistance,2,16683106
1,22.0,Malignant neoplasm progression,2,16683106
0,22.0,Thrombocytopenia,6,16683107
1,22.0,Fatigue,6,16683107
2,22.0,Anaemia,6,16683107
3,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16683107
4,22.0,Nausea,6,16683107
5,22.0,Skin toxicity,6,16683107
6,22.0,Vomiting,6,16683107
7,22.0,Hypersensitivity,6,16683107
8,22.0,Febrile neutropenia,6,16683107
9,22.0,Neutropenia,6,16683107
10,22.0,Mucosal inflammation,6,16683107
0,22.0,Acute kidney injury,5,16683158
0,22.0,Therapy cessation,,16683176
1,22.0,Faeces discoloured,,16683176
0,22.0,Non-small cell lung cancer,6,16683206
1,22.0,Adverse drug reaction,6,16683206
0,22.0,Dysphagia,6,16683221
1,22.0,Dry mouth,6,16683221
2,22.0,Stomatitis,6,16683221
3,22.0,Weight decreased,6,16683221
0,22.0,Drug resistance,6,16683222
1,22.0,Malignant neoplasm progression,6,16683222
0,22.0,Febrile neutropenia,6,16683226
1,22.0,Urosepsis,6,16683226
0,22.0,Drug resistance,6,16683247
1,22.0,Malignant neoplasm progression,6,16683247
0,22.0,Drug resistance,6,16683249
1,22.0,Malignant neoplasm progression,6,16683249
2,22.0,Coma,6,16683249
0,22.0,Drug resistance,6,16683250
1,22.0,Malignant neoplasm progression,6,16683250
0,22.0,Drug resistance,6,16683251
1,22.0,Malignant neoplasm progression,6,16683251
0,22.0,Drug resistance,6,16683252
1,22.0,Malignant neoplasm progression,6,16683252
0,22.0,Malignant neoplasm progression,6,16683253
1,22.0,Drug resistance,6,16683253
0,22.0,Oral disorder,6,16683254
1,22.0,Drug resistance,6,16683254
2,22.0,Metastases to central nervous system,6,16683254
3,22.0,Asthma,3,16683254
4,22.0,Dyspnoea,6,16683254
5,22.0,Nerve compression,6,16683254
6,22.0,Drooling,6,16683254
7,22.0,Musculoskeletal discomfort,6,16683254
8,22.0,Back pain,6,16683254
9,22.0,Chest discomfort,3,16683254
10,22.0,Hydrothorax,6,16683254
11,22.0,Peripheral swelling,1,16683254
12,22.0,Malignant neoplasm progression,6,16683254
0,22.0,Drug resistance,6,16683255
1,22.0,Malignant neoplasm progression,2,16683255
0,22.0,Malignant neoplasm progression,6,16683256
1,22.0,Metastases to neck,6,16683256
2,22.0,Pruritus,1,16683256
3,22.0,Drug resistance,6,16683256
0,22.0,Drug resistance,6,16683257
1,22.0,Malignant neoplasm progression,6,16683257
0,22.0,Drug resistance,6,16683258
1,22.0,Malignant neoplasm progression,6,16683258
0,22.0,Tubulointerstitial nephritis,2,16683270
0,22.0,Metastases to liver,6,16683271
1,22.0,Gene mutation,6,16683271
2,22.0,Colorectal cancer recurrent,6,16683271
0,22.0,Myelitis,2,16683306
1,22.0,Recall phenomenon,2,16683306
0,22.0,Interstitial lung disease,3,16683309
1,22.0,Deep vein thrombosis,2,16683309
0,22.1,Hepatic function abnormal,1,16683310
0,22.0,Constipation,1,16683311
1,22.0,Colitis ischaemic,1,16683311
0,22.1,Hepatic function abnormal,1,16683314
0,22.0,Anal incontinence,,16683327
1,22.0,Urinary incontinence,,16683327
0,22.0,Metastases to lung,3,16683329
1,22.0,Condition aggravated,6,16683329
2,22.0,Diarrhoea,1,16683329
3,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16683329
4,22.0,Dyspnoea,2,16683329
5,22.0,Cough,2,16683329
6,22.0,Skin toxicity,6,16683329
7,22.0,Weight decreased,,16683329
8,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16683329
9,22.0,Diarrhoea,6,16683329
0,22.0,Drug interaction,2,16683336
1,22.0,Dyspnoea,2,16683336
2,22.0,Urinary retention,6,16683336
3,22.0,Atrial fibrillation,6,16683336
4,22.0,Chronic obstructive pulmonary disease,2,16683336
5,22.0,Condition aggravated,2,16683336
0,22.0,Paronychia,1,16683346
1,22.0,Skin odour abnormal,1,16683346
2,22.0,Drug resistance,6,16683346
3,22.0,Skin discolouration,6,16683346
4,22.0,Skin wound,1,16683346
5,22.0,Mouth injury,1,16683346
6,22.0,Malignant neoplasm progression,6,16683346
7,22.0,Nasal injury,1,16683346
0,22.0,Drug resistance,6,16683348
1,22.0,Malignant neoplasm progression,6,16683348
0,22.0,Hip fracture,1,16683359
1,22.0,Fluid retention,1,16683359
2,22.0,Hypokalaemia,1,16683359
3,22.0,Hypertension,1,16683359
4,22.0,Hepatic cyst,1,16683359
5,22.0,Adrenal insufficiency,2,16683359
6,22.0,Fall,1,16683359
0,22.0,Disease progression,6,16683381
0,22.1,Pulmonary embolism,4,16683382
0,22.0,Dermatitis,2,16683504
0,22.0,Tumour pseudoprogression,1,16683511
1,22.0,Off label use,6,16683511
0,22.0,Cardiac dysfunction,6,16683538
0,22.0,Cardiac dysfunction,6,16683539
0,22.0,Death,5,16683676
0,22.0,Drug ineffective,3,16683678
0,22.1,Syncope,6,16683684
1,22.1,Constipation,3,16683684
2,22.1,Blood pressure increased,1,16683684
3,22.1,Nausea,3,16683684
4,22.1,Platelet count decreased,3,16683684
5,22.1,Dehydration,6,16683684
6,22.1,Blood pressure fluctuation,1,16683684
7,22.1,Dizziness,6,16683684
8,22.1,Cardiac flutter,6,16683684
9,22.1,Haemoglobin decreased,6,16683684
10,22.1,Feeling abnormal,6,16683684
11,22.1,Red blood cell count decreased,6,16683684
12,22.1,Tremor,6,16683684
0,22.1,Hypoxia,1,16683732
1,22.1,Liver disorder,6,16683732
2,22.1,Off label use,6,16683732
3,22.1,Lung disorder,1,16683732
4,22.1,Tachycardia,1,16683732
0,22.0,Cardiac dysfunction,6,16683734
0,22.0,Diarrhoea,6,16683735
1,22.0,Drug resistance,6,16683735
2,22.0,Malignant neoplasm progression,6,16683735
0,22.0,Renal impairment,,16683739
0,22.0,Osteonecrosis of jaw,3,16683766
0,22.0,Faeces discoloured,6,16683799
1,22.0,Neutropenia,6,16683799
2,22.0,Breast cancer recurrent,6,16683799
3,22.0,Metastases to liver,6,16683799
4,22.0,Diarrhoea,6,16683799
5,22.0,Fatigue,6,16683799
6,22.0,Weight increased,6,16683799
7,22.0,Anal incontinence,6,16683799
0,22.0,Decreased appetite,1,16683801
1,22.0,Erythema,1,16683801
2,22.0,Dysuria,1,16683801
3,22.0,Pyrexia,1,16683801
4,22.0,Alopecia,3,16683801
5,22.0,Neurotoxicity,1,16683801
6,22.0,Epistaxis,1,16683801
7,22.0,Constipation,1,16683801
8,22.0,Neutropenia,1,16683801
9,22.0,Platelet count decreased,3,16683801
10,22.0,Fatigue,1,16683801
0,22.0,Abdominal pain upper,2,16683802
1,22.0,Asthenia,2,16683802
0,22.0,Breast cancer,6,16683831
1,22.0,Malignant neoplasm progression,6,16683831
2,22.0,Metastases to liver,6,16683831
3,22.0,Breast cancer metastatic,6,16683831
4,22.0,Metastases to bone,6,16683831
0,22.0,Metastases to liver,6,16683832
0,22.0,Transient ischaemic attack,6,16683868
1,22.0,Blood potassium decreased,6,16683868
2,22.0,Renal failure,6,16683868
3,22.0,Hypertension,6,16683868
4,22.0,Arrhythmia,6,16683868
0,22.0,Dyspnoea exertional,2,16683919
1,22.0,Lung infiltration,2,16683919
2,22.0,Interstitial lung disease,2,16683919
0,22.0,Endometrial cancer,6,16683921
0,22.0,Respiratory failure,1,16683929
1,22.0,Malignant pleural effusion,1,16683929
2,22.0,Haemothorax,1,16683929
0,22.0,Pleural effusion,6,16683937
1,22.0,Peripheral swelling,1,16683937
2,22.0,Dyspnoea,1,16683937
3,22.0,Cough,6,16683937
4,22.0,Pericardial effusion,6,16683937
5,22.0,Cardiac failure,3,16683937
6,22.0,Hypokalaemia,6,16683937
7,22.0,Atrial fibrillation,3,16683937
8,22.0,Hyperuricaemia,6,16683937
0,22.0,Malignant neoplasm progression,6,16683990
0,22.0,Drug resistance,6,16684074
1,22.0,Malignant neoplasm progression,6,16684074
0,22.0,Death,5,16684105
0,22.0,Neuropathy peripheral,3,16684130
1,22.0,Taste disorder,3,16684130
2,22.0,Oral pain,3,16684130
3,22.0,Off label use,,16684130
4,22.0,Fatigue,3,16684130
5,22.0,Dizziness,3,16684130
6,22.0,Somnolence,3,16684130
7,22.0,Dysphonia,3,16684130
8,22.0,Abdominal pain,3,16684130
9,22.0,Pharyngeal swelling,3,16684130
10,22.0,Feeling abnormal,3,16684130
11,22.0,Dyspnoea,3,16684130
12,22.0,Blood count abnormal,6,16684130
13,22.0,Skin exfoliation,3,16684130
14,22.0,Onychoclasis,3,16684130
15,22.0,Headache,3,16684130
0,22.1,Renal impairment,6,16684144
1,22.1,Bone marrow failure,5,16684144
2,22.1,Septic shock,5,16684144
0,22.0,Hyperglycaemia,6,16684223
0,22.0,Cytokine release syndrome,1,16684260
0,22.0,Neuropathy peripheral,3,16684266
1,22.0,Protein urine present,2,16684266
0,22.1,Anaemia,1,16684290
1,22.1,Interstitial lung disease,3,16684290
0,22.0,Diarrhoea,6,16684328
1,22.0,Gallbladder disorder,6,16684328
0,22.0,Cardiac failure,6,16684329
1,22.0,Renal failure,6,16684329
0,22.1,Blood glucose increased,2,16684340
0,22.0,Drug resistance,6,16684377
1,22.0,Rash,6,16684377
2,22.0,Abdominal discomfort,6,16684377
3,22.0,Malignant neoplasm progression,6,16684377
0,22.0,Radiation pneumonitis,3,16684380
0,22.0,Blindness,1,16684393
1,22.0,Optic disc hyperaemia,1,16684393
2,22.0,Product use in unapproved indication,6,16684393
0,22.0,Macule,1,16684405
1,22.0,Angioedema,1,16684405
0,22.0,Inappropriate schedule of product administration,6,16684445
1,22.0,Dyspnoea,5,16684445
2,22.0,Chest pain,6,16684445
0,22.0,Paraesthesia,1,16684477
1,22.0,Urticaria,1,16684477
2,22.0,Rash,1,16684477
3,22.0,Peripheral swelling,1,16684477
4,22.0,Hypersensitivity,1,16684477
5,22.0,Pain,1,16684477
0,22.0,Death,5,16684479
0,22.0,Neutrophil count decreased,1,16684480
1,22.0,Platelet count decreased,1,16684480
2,22.0,Drug-induced liver injury,1,16684480
0,22.0,Lung infiltration,,16684492
0,22.1,Radiation pneumonitis,1,16684517
1,22.1,Infusion related reaction,1,16684517
0,22.0,Malignant neoplasm progression,6,16684520
1,22.0,Drug resistance,6,16684520
0,22.0,Cerebral haemorrhage,6,16684521
1,22.0,Paralysis,6,16684521
2,22.0,Malignant neoplasm progression,6,16684521
3,22.0,Nasopharyngitis,6,16684521
4,22.0,Pneumonitis,6,16684521
5,22.0,Death,5,16684521
6,22.0,Pyrexia,6,16684521
0,22.0,Nasopharyngitis,1,16684535
1,22.0,Pemphigoid,2,16684535
2,22.0,Hypothyroidism,6,16684535
3,22.0,Blood thyroid stimulating hormone increased,3,16684535
4,22.0,Chest pain,2,16684535
5,22.0,Hyperthyroidism,1,16684535
0,22.1,Drug-induced liver injury,2,16684547
1,22.1,Interstitial lung disease,2,16684547
2,22.1,Oculomucocutaneous syndrome,1,16684547
0,22.1,Cerebrovascular accident,2,16684597
1,22.1,Febrile neutropenia,1,16684597
0,22.0,Lymphadenopathy,6,16684600
1,22.0,Blood lactate dehydrogenase increased,6,16684600
2,22.0,Blood gases abnormal,6,16684600
3,22.0,Arthralgia,6,16684600
4,22.0,Soft tissue inflammation,6,16684600
5,22.0,C-reactive protein increased,6,16684600
6,22.0,Cardiogenic shock,5,16684600
7,22.0,Atrioventricular block,6,16684600
8,22.0,Reflux laryngitis,6,16684600
9,22.0,Pneumonia,5,16684600
10,22.0,Left ventricular dilatation,6,16684600
11,22.0,Left atrial dilatation,6,16684600
12,22.0,Lymphatic obstruction,6,16684600
13,22.0,Chest discomfort,5,16684600
14,22.0,Acute myocardial infarction,5,16684600
15,22.0,Tachycardia,5,16684600
16,22.0,Dyspnoea,5,16684600
17,22.0,Blood creatinine increased,6,16684600
18,22.0,Aspartate aminotransferase increased,6,16684600
19,22.0,Musculoskeletal deformity,6,16684600
20,22.0,Arteriosclerosis coronary artery,6,16684600
21,22.0,Hepatic steatosis,6,16684600
22,22.0,Blood glucose increased,6,16684600
23,22.0,Vomiting,5,16684600
24,22.0,Blood creatine phosphokinase MB increased,6,16684600
25,22.0,Pericardial effusion,6,16684600
26,22.0,Blood creatine phosphokinase increased,6,16684600
27,22.0,Aortic arteriosclerosis,6,16684600
28,22.0,Laryngeal oedema,6,16684600
29,22.0,Troponin I increased,6,16684600
30,22.0,Neoplasm progression,6,16684600
31,22.0,Nausea,5,16684600
32,22.0,Hypotension,5,16684600
33,22.0,Left ventricular failure,6,16684600
34,22.0,General physical health deterioration,6,16684600
35,22.0,Fibrin D dimer increased,6,16684600
0,22.0,Renal disorder,6,16684620
0,22.0,Hypertriglyceridaemia,3,16684635
0,22.0,Hypotension,1,16684667
1,22.0,Laryngeal oedema,1,16684667
0,22.0,Neutropenic sepsis,5,16684675
0,22.0,Rectal haemorrhage,1,16684738
1,22.0,Abdominal pain lower,1,16684738
2,22.0,Bone pain,1,16684738
3,22.0,Diverticulum intestinal,1,16684738
4,22.0,Breast pain,1,16684738
5,22.0,Arthralgia,1,16684738
0,22.0,Stomatitis,6,16684779
0,22.0,Neoplasm progression,6,16684794
0,22.0,Lethargy,3,16684817
1,22.0,Fatigue,3,16684817
2,22.0,Alopecia,3,16684817
3,22.0,Diarrhoea,1,16684817
4,22.0,Infection,1,16684817
5,22.0,Pain,1,16684817
6,22.0,Nausea,3,16684817
7,22.0,Vomiting,1,16684817
8,22.0,Foreign body sensation in eyes,3,16684817
0,22.0,Ligament rupture,4,16684820
1,22.0,Asthenia,1,16684820
2,22.0,Nail disorder,1,16684820
3,22.0,Musculoskeletal pain,1,16684820
4,22.0,Gingival bleeding,1,16684820
5,22.0,Diarrhoea,1,16684820
6,22.0,Rash,1,16684820
7,22.0,Skin hyperpigmentation,1,16684820
8,22.0,Scab,1,16684820
9,22.0,Erythema,1,16684820
10,22.0,Neuropathy peripheral,2,16684820
11,22.0,Tooth infection,1,16684820
12,22.0,Nail pigmentation,1,16684820
13,22.0,Epistaxis,1,16684820
14,22.0,Pain in extremity,1,16684820
15,22.0,Hypertension,1,16684820
16,22.0,Mouth ulceration,1,16684820
17,22.0,Dysphonia,1,16684820
18,22.0,Pseudomonas infection,1,16684820
19,22.0,Helicobacter infection,1,16684820
20,22.0,Abdominal pain upper,4,16684820
21,22.0,Ascites,1,16684820
22,22.0,Nasopharyngitis,1,16684820
23,22.0,Laryngitis,1,16684820
24,22.0,Pyrexia,1,16684820
0,22.0,Sinusitis,6,16684826
0,22.0,Hot flush,6,16684828
1,22.0,Urine output decreased,6,16684828
2,22.0,Sciatica,6,16684828
0,22.0,Diarrhoea,6,16684853
0,22.0,Hypersensitivity,1,16684863
1,22.0,Hypoxia,1,16684863
2,22.0,Hyperhidrosis,1,16684863
0,22.0,Asthenia,3,16684864
1,22.0,Decreased appetite,3,16684864
2,22.0,Jaundice,3,16684864
3,22.0,Night sweats,3,16684864
4,22.0,Musculoskeletal pain,3,16684864
5,22.0,Dysphonia,3,16684864
6,22.0,Stomatitis,3,16684864
0,22.0,Left ventricular dysfunction,1,16684866
1,22.0,Ischaemic stroke,1,16684866
2,22.0,Thrombosis,1,16684866
3,22.0,Cardiac failure,1,16684866
0,22.1,Cholangitis,5,16684876
1,22.1,Malignant neoplasm progression,5,16684876
2,22.1,Abdominal pain upper,6,16684876
0,22.0,Death,5,16684909
1,22.0,Head and neck cancer,6,16684909
2,22.0,Product use in unapproved indication,6,16684909
3,22.0,Malignant neoplasm progression,6,16684909
0,22.1,Breast cancer,6,16684920
1,22.1,Metastases to lung,6,16684920
2,22.1,Metastases to bone,6,16684920
3,22.1,Infection,6,16684920
4,22.1,Drug ineffective,6,16684920
5,22.1,Metastases to soft tissue,6,16684920
6,22.1,Metastasis,6,16684920
7,22.1,Malignant neoplasm progression,6,16684920
0,22.0,Acute kidney injury,1,16685020
1,22.0,Shock,1,16685020
0,22.1,Death,5,16685054
1,22.1,Fatigue,6,16685054
2,22.1,Weight decreased,6,16685054
3,22.1,Asthenia,6,16685054
4,22.1,Pain,6,16685054
5,22.1,Constipation,6,16685054
6,22.1,Malignant neoplasm progression,6,16685054
0,22.0,Rapidly progressive osteoarthritis,3,16685097
0,22.0,Febrile bone marrow aplasia,1,16685102
1,22.0,Hypoacusis,2,16685102
0,22.1,Platelet count decreased,1,16685106
1,22.1,Interstitial lung disease,2,16685106
2,22.1,Colitis,2,16685106
0,22.0,Surgery,6,16685130
0,22.0,Death,5,16685174
0,22.1,Malignant neoplasm progression,6,16685254
1,22.1,Metastases to liver,6,16685254
2,22.1,Therapeutic response decreased,6,16685254
0,22.1,Carcinoembryonic antigen increased,6,16685260
1,22.1,Metastases to liver,6,16685260
2,22.1,Gene mutation,6,16685260
3,22.1,Colorectal cancer recurrent,6,16685260
4,22.1,Carbohydrate antigen 19-9 increased,6,16685260
0,22.1,Metastases to lymph nodes,6,16685265
1,22.1,Therapeutic response decreased,6,16685265
0,22.1,K-ras gene mutation,6,16685270
1,22.1,Metastases to liver,6,16685270
0,22.1,Acquired gene mutation,6,16685281
1,22.1,Metastases to liver,6,16685281
0,22.1,Metastases to liver,6,16685292
1,22.1,Acquired gene mutation,6,16685292
0,22.1,Interstitial lung disease,2,16685303
0,22.0,Pharyngitis,3,16685352
0,22.1,Drug resistance,6,16685363
1,22.1,Metastases to liver,6,16685363
0,22.0,Laryngeal oedema,1,16685373
1,22.0,Hypotension,1,16685373
0,22.0,Fatigue,2,16685374
1,22.0,Condition aggravated,2,16685374
2,22.0,Hypocalcaemia,2,16685374
0,22.0,Nasopharyngitis,6,16685393
1,22.0,Rash,6,16685393
0,22.1,Alopecia,3,16685441
1,22.1,Psychological trauma,6,16685441
0,22.0,Alopecia,2,16685514
1,22.0,Psychological trauma,6,16685514
0,22.0,Alopecia,2,16685572
1,22.0,Psychological trauma,6,16685572
0,22.1,Alopecia,3,16685587
0,22.1,Psychological trauma,6,16685599
1,22.1,Impaired quality of life,6,16685599
2,22.1,Anxiety,6,16685599
3,22.1,Emotional distress,6,16685599
4,22.1,Alopecia,2,16685599
5,22.1,Pain,6,16685599
0,22.0,Ejection fraction decreased,6,16685817
1,22.0,Pericarditis,6,16685817
0,22.0,Skin infection,1,16685841
0,22.0,Product storage error,6,16685867
1,22.0,No adverse event,6,16685867
0,22.1,Dysphagia,1,16685935
1,22.1,Embolism,1,16685935
2,22.1,Stomatitis,3,16685935
3,22.1,Diarrhoea,1,16685935
4,22.1,Neuropathy peripheral,1,16685935
5,22.1,Urinary tract infection,1,16685935
6,22.1,Skin infection,1,16685935
7,22.1,Decreased appetite,1,16685935
8,22.1,Hip fracture,1,16685935
9,22.1,Pyrexia,1,16685935
10,22.1,Cardiac arrest,5,16685935
11,22.1,Neuralgia,1,16685935
12,22.1,Anaemia,1,16685935
0,22.0,Dyspnoea,6,16685957
1,22.0,Hypercalcaemia,6,16685957
0,22.0,Asthenia,3,16686033
1,22.0,Febrile bone marrow aplasia,3,16686033
2,22.0,Diarrhoea,1,16686033
0,22.0,Death,5,16686063
0,22.0,Dysphagia,2,16686130
1,22.0,Syncope,1,16686130
2,22.0,Motor neurone disease,6,16686130
3,22.0,Dysarthria,2,16686130
4,22.0,Hypotonia,2,16686130
5,22.0,Orthostatic intolerance,6,16686130
6,22.0,Peripheral sensory neuropathy,6,16686130
7,22.0,Weight decreased,6,16686130
8,22.0,Tongue disorder,2,16686130
9,22.0,Folate deficiency,6,16686130
10,22.0,Sleep apnoea syndrome,6,16686130
11,22.0,Malignant neoplasm progression,6,16686130
12,22.0,Urinary tract infection,6,16686130
13,22.0,Pain,6,16686130
0,22.0,Neuropathy peripheral,6,16686160
0,22.0,Renal disorder,6,16686212
1,22.0,Oral pain,6,16686212
2,22.0,Dermatitis acneiform,6,16686212
3,22.0,Diarrhoea,3,16686212
4,22.0,Pruritus,6,16686212
5,22.0,Rash,6,16686212
6,22.0,Peripheral swelling,3,16686212
7,22.0,Stomatitis,6,16686212
0,22.0,Interstitial lung disease,5,16686235
1,22.0,Malignant neoplasm progression,5,16686235
0,22.0,Dizziness,3,16686245
0,22.0,Scrotal exfoliation,2,16686264
1,22.0,Tenderness,2,16686264
2,22.0,Penile exfoliation,2,16686264
3,22.0,Erythema,2,16686264
0,22.0,Cardiac dysfunction,6,16686275
0,22.0,Off label use,6,16686334
0,22.0,Choking,6,16686343
1,22.0,Foreign body in respiratory tract,6,16686343
2,22.0,Cytophagic histiocytic panniculitis,6,16686343
0,22.1,Erythema,1,16686368
1,22.1,Abdominal distension,1,16686368
2,22.1,Chills,1,16686368
3,22.1,Rash,1,16686368
4,22.1,Rash pruritic,1,16686368
0,22.0,Lung neoplasm malignant,5,16686379
0,22.0,Sudden death,5,16686401
0,22.1,Colitis,1,16686406
1,22.1,Anaemia,1,16686406
2,22.1,Haematochezia,6,16686406
3,22.1,Abdominal pain,1,16686406
4,22.1,Clostridium difficile infection,2,16686406
0,22.0,Decreased appetite,6,16686430
1,22.0,Asthenia,6,16686430
2,22.0,Proteinuria,2,16686430
3,22.0,White blood cell count decreased,6,16686430
4,22.0,Off label use,6,16686430
5,22.0,Intentional product use issue,6,16686430
6,22.0,Vomiting,6,16686430
7,22.0,Pulmonary mass,6,16686430
8,22.0,Hypertension,6,16686430
9,22.0,Nausea,6,16686430
10,22.0,Constipation,6,16686430
11,22.0,Atelectasis,6,16686430
12,22.0,Skin hypertrophy,6,16686430
0,22.0,Pulmonary embolism,1,16686460
1,22.0,Prostatic specific antigen abnormal,6,16686460
0,22.0,Terminal state,6,16686463
0,22.0,Pancreatitis,1,16686464
0,22.0,Neuropathy peripheral,6,16686473
1,22.0,Thrombocytopenia,6,16686473
2,22.0,Anaemia,6,16686473
3,22.0,Neutropenia,6,16686473
0,22.1,Death,5,16686483
0,22.0,Osteonecrosis of jaw,6,16686524
0,22.0,Pulmonary embolism,1,16686531
1,22.0,Deep vein thrombosis,1,16686531
2,22.0,Tumour thrombosis,1,16686531
0,22.1,Haemorrhage,6,16686556
1,22.1,Osteonecrosis of jaw,6,16686556
0,22.0,Alopecia,3,16686563
0,22.0,Haemorrhoidal haemorrhage,6,16686578
0,22.0,Lymphadenopathy,6,16686582
1,22.0,Metastases to liver,6,16686582
2,22.0,Malignant neoplasm progression,6,16686582
3,22.0,Breast cancer metastatic,6,16686582
0,22.0,Anaphylactic shock,1,16686619
0,22.0,Intentional product use issue,6,16686621
1,22.0,Off label use,6,16686621
2,22.0,No adverse event,6,16686621
0,22.0,Colorectal cancer,,16686624
1,22.0,Hypertension,1,16686624
0,22.0,Respiratory fatigue,1,16686638
1,22.0,Laryngeal oedema,1,16686638
0,22.0,Rapidly progressive osteoarthritis,3,16686642
0,22.0,Hypertension,2,16686666
1,22.0,Diarrhoea,2,16686666
2,22.0,Pain,2,16686666
3,22.0,Rectal cancer,,16686666
4,22.0,Palmar-plantar erythrodysaesthesia syndrome,2,16686666
0,22.0,Hypotension,1,16686667
1,22.0,Tachycardia,1,16686667
0,22.1,Anal fissure,1,16686668
1,22.1,Gastric ulcer,1,16686668
2,22.1,Obstruction gastric,2,16686668
3,22.1,Haemorrhoids,1,16686668
0,22.0,Ejection fraction decreased,6,16686758
0,22.0,Neutropenia,1,16686760
1,22.0,Fatigue,2,16686760
0,22.0,Neutropenia,2,16686773
1,22.0,Colony stimulating factor therapy,6,16686773
0,22.0,Proteinuria,2,16686828
1,22.0,Nephropathy,2,16686828
0,22.0,Phlebitis,6,16686834
0,22.0,Intercepted product preparation error,6,16686840
1,22.0,Metastasis,3,16686840
2,22.0,Wrong technique in product usage process,6,16686840
3,22.0,Intentional product misuse,6,16686840
4,22.0,Inappropriate schedule of product administration,6,16686840
5,22.0,Product leakage,6,16686840
6,22.0,Drug resistance,6,16686840
7,22.0,Accidental exposure to product,6,16686840
0,22.1,Neutropenia,1,16686887
0,22.0,Skin reaction,2,16686895
0,22.1,Candida infection,6,16686919
1,22.1,Lip dry,6,16686919
2,22.1,Therapy non-responder,6,16686919
3,22.1,Deep vein thrombosis,6,16686919
4,22.1,Dry skin,6,16686919
5,22.1,Erythema,6,16686919
6,22.1,Skin fissures,1,16686919
7,22.1,Oral disorder,6,16686919
8,22.1,Device occlusion,6,16686919
9,22.1,Pain in extremity,6,16686919
10,22.1,Visual impairment,6,16686919
11,22.1,Dry throat,6,16686919
12,22.1,Clostridium difficile infection,6,16686919
13,22.1,Epistaxis,6,16686919
14,22.1,Decreased appetite,6,16686919
15,22.1,Hyperhidrosis,6,16686919
0,22.1,Interstitial lung disease,5,16686930
1,22.1,Diarrhoea,2,16686930
2,22.1,Stomatitis,2,16686930
0,22.0,Cardiac arrest,6,16686942
1,22.0,Abdominal pain,6,16686942
2,22.0,Intestinal perforation,6,16686942
3,22.0,Diarrhoea,6,16686942
4,22.0,Intestinal ischaemia,6,16686942
5,22.0,Colitis,6,16686942
6,22.0,Cardiac failure,6,16686942
0,22.0,Ascites,3,16686944
1,22.0,Clostridium difficile infection,1,16686944
0,22.0,Superinfection bacterial,4,16686969
1,22.0,Inflammation,4,16686969
2,22.0,Bladder perforation,4,16686969
3,22.0,Extravasation,4,16686969
4,22.0,Cellulitis,4,16686969
5,22.0,Pelvic infection,6,16686969
6,22.0,Muscle necrosis,4,16686969
7,22.0,Escherichia infection,4,16686969
8,22.0,Pelvic abscess,4,16686969
0,22.0,Perioral dermatitis,1,16686989
1,22.0,Rash,1,16686989
0,22.0,Off label use,6,16687016
1,22.0,Product use in unapproved indication,6,16687016
2,22.0,No adverse event,6,16687016
0,22.0,Death,5,16687084
0,22.0,Hepatic function abnormal,2,16687113
0,22.0,Feeling abnormal,6,16687212
1,22.0,Mucosal inflammation,6,16687212
0,22.0,Cardiac failure,6,16687214
0,22.0,Fatigue,6,16687253
1,22.0,Neuropathy peripheral,6,16687253
2,22.0,Lethargy,6,16687253
3,22.0,Pain in extremity,6,16687253
0,22.0,Myocardial infarction,2,16687272
0,22.0,Death,,16687303
0,22.1,Disease progression,,16687385
0,22.1,Deep vein thrombosis,,16687411
1,22.1,Pulmonary embolism,,16687411
0,22.0,Cholelithiasis,,16687431
0,22.0,Tubulointerstitial nephritis,6,16687451
1,22.0,Renal tubular injury,6,16687451
2,22.0,Blood creatinine increased,3,16687451
3,22.0,Fatigue,6,16687451
4,22.0,Pneumonitis,1,16687451
5,22.0,Dyspnoea,1,16687451
6,22.0,Malaise,6,16687451
7,22.0,Blood creatinine increased,6,16687451
0,22.1,Malignant neoplasm progression,6,16687470
1,22.1,Pericardial effusion malignant,6,16687470
2,22.1,Oedema peripheral,3,16687470
3,22.1,Gait disturbance,3,16687470
4,22.1,Muscular weakness,3,16687470
0,22.0,Fatigue,,16687492
1,22.0,Asthenia,,16687492
0,22.1,Dyspnoea,,16687500
1,22.1,Cardiac valve disease,,16687500
0,22.1,Asthenia,,16687519
1,22.1,Blood glucose increased,,16687519
0,22.1,Constipation,,16687543
1,22.1,Nausea,,16687543
2,22.1,Vomiting,,16687543
3,22.1,Gallbladder operation,,16687543
4,22.1,Diarrhoea,,16687543
0,22.0,Hyperaesthesia,5,16687554
1,22.0,Delirium,6,16687554
2,22.0,Mental status changes,6,16687554
3,22.0,Drug ineffective,6,16687554
4,22.0,Anxiety,5,16687554
0,22.1,Prostate cancer metastatic,5,16687563
0,22.1,Death,,16687567
0,22.0,Adverse drug reaction,6,16687624
0,22.1,Hypersensitivity,6,16687700
1,22.1,Pruritus,3,16687700
2,22.1,Urticaria,1,16687700
0,22.1,Malignant neoplasm progression,3,16687704
1,22.1,Pleural effusion,6,16687704
2,22.1,Bone marrow haemorrhage,3,16687704
3,22.1,Subdural haematoma,3,16687704
4,22.1,Intra-abdominal haemorrhage,3,16687704
0,22.1,Hypertension,6,16687717
1,22.1,Amylase increased,6,16687717
2,22.1,Lipase increased,6,16687717
3,22.1,Arthralgia,6,16687717
4,22.1,Aspartate aminotransferase increased,6,16687717
5,22.1,Skin disorder,6,16687717
6,22.1,Myalgia,6,16687717
7,22.1,Alanine aminotransferase increased,6,16687717
0,22.1,Insomnia,6,16687745
1,22.1,White blood cell count decreased,6,16687745
2,22.1,Fatigue,6,16687745
3,22.1,Alopecia,6,16687745
0,22.1,Neoplasm progression,6,16687751
1,22.1,Rash,6,16687751
2,22.1,Fatigue,6,16687751
3,22.1,Asthenia,6,16687751
4,22.1,Pruritus,6,16687751
0,22.0,Fracture,6,16687753
0,22.0,Diabetic ketoacidosis,1,16687754
0,22.1,White blood cell count decreased,2,16687758
1,22.1,Febrile neutropenia,2,16687758
2,22.1,Malignant neoplasm progression,6,16687758
3,22.1,Neutrophil count decreased,2,16687758
4,22.1,Anaemia,2,16687758
5,22.1,Diarrhoea,2,16687758
0,22.0,Visual acuity reduced,6,16687787
1,22.0,Thrombocytopenia,1,16687787
2,22.0,Photosensitivity reaction,6,16687787
3,22.0,Neutropenia,6,16687787
4,22.0,Pneumonia,6,16687787
5,22.0,Cough,6,16687787
6,22.0,White blood cell count decreased,3,16687787
0,22.1,Skin exfoliation,3,16687788
1,22.1,Product prescribing error,6,16687788
2,22.1,Pruritus,6,16687788
3,22.1,Muscle spasms,1,16687788
4,22.1,Dehydration,6,16687788
5,22.1,Alopecia,3,16687788
6,22.1,Pain of skin,6,16687788
7,22.1,Skin burning sensation,6,16687788
8,22.1,Diarrhoea,1,16687788
0,22.0,Radiation pneumonitis,3,16687798
1,22.0,Platelet count decreased,1,16687798
0,22.0,Product dose omission,6,16687799
1,22.0,Product use in unapproved indication,6,16687799
2,22.0,Off label use,6,16687799
3,22.0,Vomiting,6,16687799
0,22.0,Pyrexia,6,16687816
0,22.0,Pneumonitis,6,16687836
1,22.0,Intentional product use issue,6,16687836
0,22.0,Death,,16687851
0,22.0,Alpha 1 foetoprotein increased,,16687882
1,22.0,Pre-existing condition improved,,16687882
2,22.0,Drug ineffective,,16687882
0,22.0,Death,,16687884
0,22.1,Death,,16687893
0,22.0,Pancreatitis,1,16687958
0,22.1,Cardiomyopathy,,16687991
1,22.1,Cardiac failure congestive,,16687991
0,22.0,Loss of consciousness,6,16688021
1,22.0,Circulatory collapse,6,16688021
0,22.0,Haemoglobin decreased,2,16688046
1,22.0,Renal impairment,2,16688046
2,22.0,Blood creatinine abnormal,2,16688046
0,22.0,Rash,6,16688050
1,22.0,Off label use,6,16688050
2,22.0,Malaise,3,16688050
3,22.0,Decreased appetite,3,16688050
4,22.0,Nausea,3,16688050
5,22.0,Pruritus,6,16688050
6,22.0,Dyspepsia,6,16688050
7,22.0,Dehydration,6,16688050
8,22.0,Diarrhoea,3,16688050
9,22.0,Hypophagia,3,16688050
10,22.0,Dyspepsia,3,16688050
11,22.0,Vomiting,6,16688050
12,22.0,Product use in unapproved indication,6,16688050
13,22.0,Malignant neoplasm progression,6,16688050
14,22.0,Weight decreased,3,16688050
15,22.0,Vertigo,1,16688050
16,22.0,Gastrooesophageal reflux disease,6,16688050
17,22.0,Bone pain,6,16688050
18,22.0,Fatigue,3,16688050
19,22.0,Asthenia,3,16688050
20,22.0,Intentional product misuse,3,16688050
0,22.0,Hyponatraemia,1,16688091
0,22.0,Knee arthroplasty,1,16688186
1,22.0,Drug ineffective,6,16688186
2,22.0,Prostatic specific antigen increased,6,16688186
3,22.0,Aortic valve replacement,1,16688186
4,22.0,Cardiac pacemaker insertion,1,16688186
0,22.0,Myocarditis,5,16688206
0,22.1,Neutropenia,1,16688215
1,22.1,Blood alkaline phosphatase increased,2,16688215
2,22.1,Aspartate aminotransferase increased,2,16688215
3,22.1,Alanine aminotransferase increased,3,16688215
0,22.0,Cognitive disorder,6,16688218
0,22.0,Constipation,6,16688262
1,22.0,Influenza,3,16688262
2,22.0,Muscle spasms,3,16688262
3,22.0,Crying,3,16688262
4,22.0,Fatigue,3,16688262
5,22.0,Bladder disorder,3,16688262
6,22.0,Abdominal discomfort,3,16688262
7,22.0,Amnesia,3,16688262
0,22.1,Pain,6,16688280
1,22.1,Arthralgia,6,16688280
2,22.1,Neuropathy peripheral,6,16688280
0,22.0,Renal failure,3,16688290
1,22.0,Blood pressure abnormal,3,16688290
2,22.0,Lung infiltration,3,16688290
3,22.0,Pyrexia,3,16688290
4,22.0,Off label use,6,16688290
5,22.0,Unresponsive to stimuli,6,16688290
6,22.0,Pneumonia,3,16688290
0,22.0,Death,5,16688328
0,22.0,Decreased appetite,1,16688333
1,22.0,Thrombocytopenia,1,16688333
2,22.0,Renal failure,1,16688333
3,22.0,Leukopenia,1,16688333
4,22.0,Neutropenia,1,16688333
5,22.0,Hypertension,1,16688333
6,22.0,Eye irritation,1,16688333
0,22.1,Erythema,1,16688342
1,22.1,Skin toxicity,1,16688342
0,22.1,Malignant neoplasm progression,5,16688362
1,22.1,Renal failure,6,16688362
2,22.1,Loss of consciousness,5,16688362
0,22.0,Colon cancer,3,16688377
1,22.0,Pneumonia,2,16688377
0,22.0,Myelitis,1,16688382
0,22.0,Pelvic pain,,16688435
1,22.0,Neutrophil count decreased,3,16688435
2,22.0,Pain in jaw,,16688435
0,22.0,Off label use,,16688441
1,22.0,Hospitalisation,,16688441
0,22.0,Dyspnoea,6,16688445
1,22.0,Pneumonia,6,16688445
0,22.1,Metastases to liver,6,16688453
1,22.1,Pseudocirrhosis,6,16688453
2,22.1,Neoplasm recurrence,6,16688453
3,22.1,Febrile neutropenia,6,16688453
4,22.1,Breast cancer,5,16688453
0,22.0,Pain in jaw,3,16688462
1,22.0,Lymphadenopathy,3,16688462
2,22.0,Muscle spasms,3,16688462
3,22.0,Paraesthesia,3,16688462
4,22.0,Lymphoedema,3,16688462
5,22.0,Musculoskeletal pain,3,16688462
6,22.0,Injection site paraesthesia,3,16688462
7,22.0,Neck pain,3,16688462
8,22.0,Musculoskeletal stiffness,3,16688462
0,22.0,Osteonecrosis of jaw,6,16688601
1,22.0,Drug-induced liver injury,6,16688601
2,22.0,Gastric varices haemorrhage,6,16688601
0,22.0,Pain,3,16688644
1,22.0,Chest pain,3,16688644
2,22.0,Back pain,3,16688644
3,22.0,Pain in extremity,3,16688644
0,22.1,Feeding disorder,2,16688685
1,22.1,Asthenia,2,16688685
2,22.1,Metastasis,6,16688685
3,22.1,Malaise,2,16688685
4,22.1,Neoplasm malignant,6,16688685
5,22.1,Prostate cancer,5,16688685
0,22.0,Renal failure,1,16688696
1,22.0,Anaemia,1,16688696
2,22.0,Leukopenia,1,16688696
3,22.0,Thrombocytopenia,1,16688696
4,22.0,Oedema peripheral,1,16688696
5,22.0,Hypertension,1,16688696
6,22.0,Hypothyroidism,1,16688696
7,22.0,Epistaxis,1,16688696
8,22.0,Genital haemorrhage,1,16688696
9,22.0,Neutropenia,1,16688696
10,22.0,Herpes zoster,1,16688696
0,22.0,Pancytopenia,2,16688708
0,22.0,Anaemia,1,16688709
1,22.0,Hypertension,1,16688709
2,22.0,Night sweats,1,16688709
3,22.0,Decreased appetite,1,16688709
4,22.0,Thrombocytosis,1,16688709
5,22.0,Pain in extremity,1,16688709
6,22.0,Syncope,6,16688709
7,22.0,Suffocation feeling,1,16688709
8,22.0,Diarrhoea,1,16688709
9,22.0,Vomiting,1,16688709
10,22.0,Fatigue,1,16688709
0,22.0,Rash,6,16688761
1,22.0,Lip disorder,6,16688761
2,22.0,Toxic epidermal necrolysis,6,16688761
3,22.0,Death,5,16688761
4,22.0,Chapped lips,6,16688761
5,22.0,Adverse event,6,16688761
0,22.0,Drug level decreased,6,16688768
1,22.0,Drug interaction,6,16688768
0,22.0,Photosensitivity reaction,2,16688776
0,22.1,Death,5,16688780
0,22.1,Headache,,16688804
0,22.0,Death,,16688828
0,22.1,Asthenia,,16688916
1,22.1,Chills,,16688916
0,22.0,Encephalitis autoimmune,6,16688921
0,22.1,Death,,16688924
0,22.0,Metastases to central nervous system,6,16688970
1,22.0,Adrenal insufficiency,6,16688970
2,22.0,Muscular weakness,6,16688970
3,22.0,Gait disturbance,6,16688970
0,22.0,Death,5,16688974
0,22.0,Malignant pleural effusion,6,16689059
1,22.0,Radiation pneumonitis,6,16689059
0,22.0,Skin lesion,6,16689074
1,22.0,Asthenia,6,16689074
2,22.0,Diarrhoea,6,16689074
3,22.0,Mucosal inflammation,6,16689074
4,22.0,Neuropathy peripheral,1,16689074
5,22.0,Abdominal pain upper,6,16689074
6,22.0,Decreased appetite,6,16689074
7,22.0,Skin toxicity,6,16689074
0,22.1,Medical device site infection,6,16689078
1,22.1,Urinary tract infection,6,16689078
2,22.1,Small intestinal obstruction,1,16689078
3,22.1,Infection,6,16689078
4,22.1,Neutropenia,6,16689078
0,22.0,Death,5,16689106
0,22.0,Metastases to bone,6,16689107
1,22.0,Metastases to liver,6,16689107
0,22.0,Obesity,5,16689111
1,22.0,Glaucoma,5,16689111
2,22.0,Colorectal cancer metastatic,5,16689111
3,22.0,End stage renal disease,5,16689111
4,22.0,Cardiac failure congestive,5,16689111
0,22.0,Intestinal obstruction,1,16689124
1,22.0,Inappropriate schedule of product administration,6,16689124
0,22.0,Transaminases increased,2,16689129
1,22.0,Rash maculo-papular,6,16689129
2,22.0,Stomatitis,6,16689129
3,22.0,Adrenal insufficiency,6,16689129
4,22.0,Anal inflammation,6,16689129
0,22.0,Immune-mediated hepatitis,6,16689138
1,22.0,Odynophagia,6,16689138
2,22.0,Stomatitis,6,16689138
0,22.1,Diarrhoea,1,16689139
1,22.1,Migraine,6,16689139
2,22.1,Thyroid mass,6,16689139
3,22.1,Prescribed underdose,6,16689139
0,22.0,Nausea,6,16689142
1,22.0,Neutrophil count decreased,6,16689142
2,22.0,Pancytopenia,6,16689142
3,22.0,Liver function test abnormal,6,16689142
0,22.0,Hypercalcaemia,1,16689146
0,22.0,Death,5,16689176
1,22.0,Hospitalisation,6,16689176
0,22.0,Blood count abnormal,3,16689183
1,22.0,Pyrexia,6,16689183
2,22.0,Fatigue,3,16689183
3,22.0,Deep vein thrombosis,3,16689183
4,22.0,Abdominal pain upper,3,16689183
5,22.0,Malaise,6,16689183
0,22.0,Drug eruption,6,16689190
1,22.0,Immune thrombocytopenic purpura,6,16689190
2,22.0,Platelet count decreased,6,16689190
3,22.0,Pleural effusion,6,16689190
4,22.0,Interstitial lung disease,2,16689190
0,22.0,Malignant neoplasm progression,3,16689193
0,22.0,Hormone-refractory prostate cancer,5,16689197
0,22.0,Anaemia,1,16689208
1,22.0,Sepsis,1,16689208
0,22.0,Orchidectomy,6,16689243
1,22.0,Prostatic specific antigen increased,6,16689243
2,22.0,Hot flush,6,16689243
0,22.1,Inflammation,6,16689261
1,22.1,Renal impairment,2,16689261
0,22.0,Metastases to bone,6,16689262
1,22.0,Pleuritic pain,6,16689262
2,22.0,Rash,6,16689262
3,22.0,Drug resistance,6,16689262
4,22.0,Metastases to ovary,6,16689262
5,22.0,Nodule,6,16689262
6,22.0,Nasopharyngitis,6,16689262
7,22.0,Dysphagia,6,16689262
8,22.0,Pyrexia,6,16689262
9,22.0,Pleural thickening,6,16689262
10,22.0,Respiratory failure,6,16689262
11,22.0,Nasal herpes,6,16689262
12,22.0,Diarrhoea,6,16689262
13,22.0,Inappropriate schedule of product administration,6,16689262
0,22.1,Hypopituitarism,2,16689279
1,22.1,Dizziness,6,16689279
2,22.1,Subarachnoid haemorrhage,6,16689279
3,22.1,Fall,6,16689279
0,22.0,Pneumonia,5,16689280
0,22.0,Diarrhoea,3,16689303
0,22.0,Dehydration,6,16689307
1,22.0,Blood creatinine increased,6,16689307
2,22.0,Acute kidney injury,6,16689307
0,22.1,Urinary tract infection,1,16689311
0,22.0,Radiation injury,6,16689312
1,22.0,Breast cancer metastatic,6,16689312
2,22.0,Off label use,6,16689312
0,22.0,Malignant neoplasm progression,6,16689316
1,22.0,Neutropenia,6,16689316
2,22.0,Neuropathy peripheral,3,16689316
3,22.0,Thrombocytopenia,6,16689316
4,22.0,Anaemia,6,16689316
0,22.0,Malignant pleural effusion,6,16689319
1,22.0,Interstitial lung disease,2,16689319
0,22.0,Metastases to central nervous system,6,16689321
1,22.0,Malignant neoplasm progression,6,16689321
0,22.1,Diarrhoea,4,16689334
1,22.1,Fatigue,1,16689334
2,22.1,Polyneuropathy,1,16689334
3,22.1,Oedema peripheral,3,16689334
4,22.1,Off label use,6,16689334
0,22.0,Off label use,1,16689377
1,22.0,Malignant neoplasm progression,6,16689377
2,22.0,Product use in unapproved indication,1,16689377
0,22.0,Spondylitis,6,16689385
1,22.0,Off label use,6,16689385
2,22.0,Sacroiliitis,6,16689385
3,22.0,Fatigue,6,16689385
4,22.0,Drug ineffective for unapproved indication,6,16689385
0,22.0,Fall,5,16689386
0,22.0,Intentional product use issue,6,16689399
1,22.0,Delirium,6,16689399
0,22.1,Neutrophil count decreased,1,16689400
1,22.1,Fatigue,2,16689400
2,22.1,Neutrophil count decreased,1,16689400
0,22.0,Hypokalaemia,6,16689402
1,22.0,Tremor,6,16689402
0,22.1,Hair texture abnormal,3,16689457
1,22.1,Alopecia,3,16689457
2,22.1,Hair colour changes,3,16689457
3,22.1,Hair disorder,3,16689457
